BioCentury
ARTICLE | Clinical News

Celldex preclinical data

April 21, 2014 7:00 AM UTC

In mouse xenograft models of ovarian cancer and RCC, 75, 150 and 300 µg intraperitoneal injections of CDX-014 on days 0, 4, 8 and 12 each significantly improved percent survival vs. saline-treated con...